United Kingdom

People: Zealand Pharma A/S (ZEAL.OQ)

ZEAL.OQ on NASDAQ Stock Exchange Global Select Market

9:00pm BST
Change (% chg)

$0.38 (+1.81%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Garcia, Marino 

Mr. Marino Garcia is Senior Vice President, Corporate and Business Development of the Company. Marino holds a Bachelor’s Degree in Business Administration from Concordia University in Montreal, Quebec, and an MBA from the Richard Ivey School of Business at Western University in London, Ontario. Prior to joining Zealand, Marino was instrumental in leading business development and corporate strategy at Synergy Pharmaceuticals Inc. Marino has more than 20 years of global experience in commercial, operational, corporate strategy, and business development. He has held various U.S. and international leadership roles of increasing responsibility at pharmaceutical companies, including Aptalis Pharma, Aspreva Pharmaceuticals, Eli Lilly & Co, Schering Plough, and Pfizer.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --